Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Indiplon capsules regulatory update

NBIX received a second approvable letter from FDA for indiplon 5 and 10 mg capsules to treat insomnia. According

Read the full 196 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE